熱門資訊> 正文
STAAR外科报告第二季度销售额超过9000万美元
2026-07-17 18:21
- STAAR Surgical (STAA) shares fell nearly 12% even as the company reported preliminary second-quarter net sales of more than $90M that topped analysts' estimate of $89.39M and more than doubled from $44.3M a year earlier.
- The company said sales were driven by sequential growth in China, solid gains across the broader Asia-Pacific region, and double-digit percentage growth in the Americas.
- However, sales in the Middle East and parts of Europe, the Middle East and Africa (EMEA), and Asia-Pacific remained under pressure from geopolitical and macroeconomic headwinds. STAAR warned that if those conditions persist or worsen, they could continue to weigh on future sales growth.
More on STAAR Surgical
- STAAR Surgical Company (STAA) Discusses Differentiation of EVO ICL Technology and Market Trends in Refractive Surgery Transcript
- STAAR Surgical Q1 2026: Early Signs Of A Durable Turnaround
- STAAR Surgical Company (STAA) Q1 2026 Earnings Call Transcript
- Wall Street raises STAAR Surgical price target to $40 on Q1 beat: STAA rally analysis
- STAAR Surgical rises on Q1 beat; Wedbush upgrades on China recovery
推薦文章
美股前瞻 | 韓國KOSPI指數狂飆18%！SK海力士盤前再升逾6%；特朗普政府入股七家晶片公司；亞馬遜盤前勁升11%
一周財經日曆 | 7月大小非農重磅來襲；SpaceX迎首份財報+鉅額解禁，匯豐、閃迪、Palantir、AMD財報輪番登場
從「無人問津」到全球資金「新寵」！恆指月內飆升近13%，三路「活水」強勢匯入，港股還能強多久？
華盛早報 | 美股上演"AI大奇蹟日」！閃迪漲25%、美光漲18%；微軟暴漲15%創18年來最大漲幅；巨頭績后分化，亞馬遜大漲近10%，蘋果跌近6%
7月31日外盤頭條：亞馬遜雲業務營收大增37% OpenAI降價至多80%鞏固市場 蘋果iPhone銷量同比大漲22%
美股前瞻 | 聚焦20：30！沃什「欽點」核心PCE攜GDP數據齊登場；晶片股盤前強勢反攻，閃迪升近6%；蘋果、亞馬遜盤后放榜
全文|Meta Q2業績會實錄：消費級個人智能體最終市場會很廣闊
債市「用腳投票」：沃什鷹派言論難敵按兵不動，30年期美債收益率飆至19年新高
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
